The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial

Overview of attention for article published in Respiratory Research, September 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 1 news outlet

twitter: 1 X user

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 147 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 1 outlets.

The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial - Docwire News

Doc Wire News, 16 Sep 2021

This article was originally published here Respir Res. 2021 Sep 15;22(1):245. doi: 10.1186/s12931-021-01833-6.

The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial - Docwire News

Doc Wire News, 16 Sep 2021

This article was originally published here Respir Res. 2021 Sep 15;22(1):245. doi: 10.1186/s12931-021-01833-6.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.